Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM ... MarketWatch (press release) Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM) (CBLB502) on Graft-Versus-Tumor Activity in Models of Allogeneic Bone Marrow Transplantation. BUFFALO, N.Y., Nov 6, 2012 (GlobeNewswire via COMTEX) -- Cleveland ... |
